Quick ReadPlain-language overview · read this first
This is a U.S. defense company that makes drones. The report’s stance is “Watch”: a good company has met bad timing, so it is better to monitor it first rather than rush to buy.
It mainly makes small military drones, along with something called a “loitering munition.” This can fit into a backpack and be launched by an individual soldier. It flies over a target area, circles while waiting, and then dives to attack after locking on, effectively combining reconnaissance and strike in one system. It is now riding the strongest tailwind: wars increasingly depend on drones, the U.S. military plans to equip “each squad with one drone,” related procurement budgets have been raised sharply, and AeroVironment is one of the few suppliers with ready products, production lines, and real battlefield experience. Orders are pouring in.
The trouble comes from last year’s scale-doubling acquisition. The newly acquired space business stumbled, a major contract was halted, and the company recognized a one-time impairment. Although revenue surged in the latest quarter, profit swung from positive to negative. The most glaring issue is earning power: in the past, every $100 of goods sold left $38 behind; now only $24 remains, a large shrinkage. The company also cut its own full-year expectations.
On price, the share price has already fallen from a high of $417 to around $204, down by more than half, so a lot of the bad news has been digested. But the report argues that it is still not cheap: the company is losing money on a reported basis, its earning power has just fallen to a trough, and the risk of having overpaid has not been fully ruled out. It suggests waiting until profit stabilizes and orders truly turn into revenue. The ideal buy price is below $175, where there would be enough margin of safety.
The above is only a plain-language explanation of this report and is not investment advice. The stock market involves risk, and investors should proceed with caution.
LeadAeroVironment is a core U.S. supplier of loitering munitions (Switchblade) and small drones (Puma/Raven), positioned directly in the strongest defense tailwind of this cycle: drone dominance. The central thesis is that a first-rate franchise is meeting a costly integration stumble after the $4.1 billion all-stock BlueHalo acquisition, with the Q3 revenue miss, gross margin compression from 38% to 24%, a $151 million space goodwill impairment, lowered full-year guidance, a GAAP loss, and securities class-action litigation all surfacing at once. Rating Watch: a durable compounder in a powerful market, but the better entry point is after integration stabilizes or below $175.
Prices in the article are as of publication; see the valuation band above for the live price.
This report applies the Zen Horizon Framework: vertically, it examines where a company came from and how the intrinsic quality of its business has evolved over time; horizontally, it assesses where the company stands in the industry chain and competitive landscape, and whether it is expensive or cheap relative to peers; finally, the vertical and horizontal lines meet in valuation and scenarios to produce a rating and an ideal buy range. All financial data in this report are based on AeroVironment's public disclosures through Q3 FY2026 (quarter ended January 31, 2026), with the share-price anchor at about $204.40 intraday on June 5, 2026.
Research Summary: First-Rate End Market, First-Rate Franchise, Costly Integration Stumble
AeroVironment (Nasdaq: AVAV, hereafter "AV") is a U.S. defense technology company whose fate is tightly tied to the central theme of "drone warfare." Its core business has two parts. The first is its original Autonomous Systems business, represented by Switchblade loitering munitions and Puma/Raven small unmanned reconnaissance aircraft, making AV a primary supplier of squad- and platoon-level unmanned equipment to the U.S. military and dozens of allied forces. The second is the Space, Cyber & Directed Energy business it obtained through the May 2025 all-stock acquisition of BlueHalo, extending AV into satellite communications, directed-energy weapons, electronic warfare, and counter-drone systems. After the acquisition closed, AV's revenue base roughly doubled, transforming it from a pure-play drone company into a mid-sized defense platform spanning "reconnaissance-strike unmanned systems + space and multi-domain operations."
At mid-2026, the bull and bear forces around this company are both unusually clear, almost a textbook case of "a good company in a good market meeting bad timing":
Bull case: this is the strongest defense tailwind of this generation. Drones are moving from "auxiliary reconnaissance tools" to "primary battlefield consumables," a trend vividly demonstrated by the war in Ukraine. The U.S. Department of Defense launched Replicator in 2023 to deploy thousands of autonomous systems within 18-24 months, and AV's Switchblade 600 was the first weapon officially named for inclusion in Replicator. In July 2025, Defense Secretary Hegseth signed the "Unleashing U.S. Military Drone Dominance" memorandum, calling for "one drone per squad" by the end of 2026 and deployment of more than 200,000 drones by 2027. In the FY2027 budget request, related "Drone Dominance / DAWG" items rose from a mere $225 million to about $54.6 billion (including $39.2 billion in mandatory funding requests). This is a franchise-level demand inflection, and AV is one of the few pure-play names in the field with scaled delivery records, program positions, and existing production lines. Orders are also coming through: the 9-month rolling book-to-bill reached 1.6x, year-to-date new bookings were $4.6 billion, and unfunded backlog was $3.0 billion.
Bear case: buying today means buying a company whose integration risk is on the table and whose reported numbers are at their ugliest point. Q3 FY2026 (quarter ended January 31, 2026) concentrated nearly every issue that tends to surface during a post-acquisition digestion period: revenue was $408 million, up 143% year over year but below market expectations of about $484 million; gross margin compressed from 38% in the prior-year period to 24% (intangible-asset amortization from the acquisition plus product-mix dilution); the space business recorded a $151 million goodwill impairment triggered by a stop-work order (the related SCAR contract was formally terminated for convenience by the Space Force in March 2026); the company then cut FY2026 revenue guidance to $1.85-1.95 billion and guided to a full-year GAAP net loss of $201-218 million; after the report, it also faced a securities class-action lawsuit. The market voted with its feet. The stock fell from a peak of $417.86 in October 2025 to around $204 today, more than halving (-51%).
Rating after the horizontal and vertical lines meet: Watch. The company's franchise (Switchblade/Puma's position in U.S. military inventories) and end market (drone dominance) are both first-rate; the long runway is not in doubt. But a "good company" is not the same as "a good price right now." At present, investors are buying a company with gross margin at a historical low, full-year guidance just cut, integration execution risk newly visible, and $2.46 billion of goodwill impairment exposure still on the balance sheet. Its 5.4x price-to-sales ratio remains 2-3x that of traditional defense primes (Lockheed at 1.83x, General Dynamics at 1.81x), so valuation is not cheap. The positive side is that a 51% drawdown has already priced in a meaningful portion of the bad news, while the average analyst target of $309.88 still implies about 50% upside. Overall judgment: the odds improve if investors wait until integration stabilizes, gross margin is confirmed to be recovering, and the $4.6 billion in bookings demonstrably converts into revenue; the ideal buy range is below $175 (near the 52-week low of $156 and with price-to-sales falling back to just above 4x). At the current $204 level, risk-reward is not yet clean enough for action.
The rest of this report follows the Zen Horizon Framework layer by layer: vertically, how AV grew from a California model-aircraft company into a drone leader, and how its business quality has evolved; horizontally, how it compares with peers in the defense-technology landscape and whether it is expensive or cheap; finally, valuation and a pre-mortem bring the two lines together.
Vertical Analysis (I): From Solar Aircraft to Loitering-Munition Leader, 55 Years of "Aircraft Engineering Geek" DNA
To understand AV's character today, start with its origin. At its core, this is an "extreme aircraft engineering" organization, not a traditional arms contractor.
In 1971, Paul MacCready founded AeroVironment. MacCready was one of the most legendary aeronautical engineers of the 20th century and was known as the "father of human-powered flight." He built the first truly practical human-powered aircraft, the Gossamer Condor (winner of the Kremer Prize in 1977), the first human-powered aircraft to cross the English Channel, the Gossamer Albatross (1979), as well as the Solar Challenger solar aircraft, the Sunraycer solar car for General Motors, and NASA's record-setting high-altitude solar UAV Helios (which reached 29.5 kilometers). This engineering gene of being light, clever, and extremely energy-efficient became AV's underlying capability in small drones: packing sensors, power, and endurance into the smallest practical airframe.
From research projects to military drones. During the 1980s-2000s, AV gradually redirected its high-altitude long-endurance, miniaturization, and electric-propulsion capabilities toward military small unmanned reconnaissance aircraft (UAS). Raven (RQ-11, mass production from 2003) became one of the most heavily procured small drones in U.S. military history. Cumulative deliveries of the Puma/Raven series exceed 19,000 units, equipping more than 50 allied militaries. This is the source of AV's near-monopoly installed-base moat in squad- and platoon-level unmanned reconnaissance.
2007 IPO on Nasdaq. After listing, AV entered a dual-core stage of "small drones + charging infrastructure" (it also made EV fast chargers in its earlier years), then gradually divested non-core businesses and focused on defense unmanned systems.
2010s: it bet on loitering munitions, and the bet was right. AV launched Switchblade 300 in 2011, a small loitering munition that can fit in a backpack, be launched by a single soldier, loiter above a target, and dive to strike after lock-on. It was a niche category at the time, but later proved to be a core form of "drone warfare." Switchblade combines reconnaissance and strike, allowing one soldier to complete the find-decide-strike loop at a fraction of the cost of conventional missiles. Switchblade entered U.S. military inventories in 2015. After the Russia-Ukraine war began in 2022, the United States supplied large numbers of Switchblade 300/600 systems to Ukraine, and combat performance pushed the category firmly into the mainstream. Loitering munitions moved from "nice-to-have" to "munition-grade consumables on the modern battlefield." At that inflection point, AV was one of the few Western suppliers with mature products, production capacity, and combat data.
May 1, 2025: all-stock acquisition of BlueHalo, doubling scale and sharply changing the company's character. This was the largest strategic move in AV's history and the source of all the tensions in this report. AV acquired BlueHalo (seller: private-equity firm Arlington Capital Partners) in an all-stock transaction with an enterprise value of about $4.1 billion. AV issued about 18.5 million shares; after closing, legacy AV shareholders owned about 60.5%, and legacy BlueHalo shareholders about 39.5%. BlueHalo brought an entire set of capabilities AV previously lacked: space (satellite communications and space-domain awareness), directed-energy weapons, electronic warfare, counter-drone systems, and cyber. The deal transformed AV from a single-category "small drones + loitering munitions" company into a mid-sized defense platform spanning "autonomous systems + space and multi-domain operations," directly doubling its revenue base.
Vertical takeaway: AV's lineage is "extreme aircraft engineering." Its moat is the installed base, combat data, and procurement relationships that Switchblade/Puma have accumulated across the U.S. military and allied forces over decades. In the 2010s, it made the right directional bet on loitering munitions and caught the historical inflection in drone warfare. But the 2025 all-stock acquisition that doubled its size turned what had been a "small, elegant, high-margin, pure-play drone" company into a "larger, more complex, goodwill-heavy, still-digesting" multi-domain platform. Vertically, this is AV's key leap from franchise to platform, and the source of its current financial pain.
Vertical Analysis (II): Current Slice of the Two Segments - Autonomous Systems Is Flying, Space Is Dragging
After acquiring BlueHalo, AV reorganized into two reportable segments. Understanding the state of each segment is the key to understanding the company's current fundamentals.
Segment One: Autonomous Systems (AxS) - The Engine Is Still Roaring
This is AV's core business. Q3 FY2026 revenue was about $278.7 million, or about 68% of total company revenue, up about 24.8% year over year. It contains two internal lines:
Unmanned Aircraft Systems (UAS): Puma, Raven, Wasp, JUMP 20, and other small and medium-sized reconnaissance/multi-purpose drones. Q3 revenue was about $90 million, up +50.3% year over year. Demand is driven by "drone dominance" policy and allied restocking. In November 2025, AV received a U.S. Army contract worth about $874 million.
Precision Strike, meaning loitering munitions: Switchblade 300/400/600 series. Q3 revenue was about $158 million, up +21.4% year over year. This is AV's most certain growth business and the one with the most direct policy benefit. Switchblade 600 was the first Replicator-named weapon; in August 2024, AV won a $990 million IDIQ (indefinite-delivery/indefinite-quantity) framework, followed in October 2024 by about $743 million of additional contract ceiling (covering the U.S. military and allies such as Lithuania, Romania, and Sweden, including foreign military sales). In February 2026, it received about $186 million of additional orders, and in May 2026 it won the Army LASSO (Switchblade 400) selection, with contract value undisclosed.
Autonomous Systems is the "good business" part of AV: fast growth, the most direct policy tailwind, and the thickest moat. It is the engine supporting the entire investment thesis.
Segment Two: Space, Cyber & Directed Energy (SCDE) - The Current Drag
This is the new business brought by BlueHalo. Q3 FY2026 revenue was about $129.3 million, or about 32% of total company revenue, down about 19.2% year over year. The decline was caused by delays in government funding and the impact of a government shutdown. This business is highly dependent on the cadence of government R&D and procurement budgets, and the beginning of fiscal 2026 saw sharp federal budget volatility.
More importantly, this business triggered the most conspicuous impairment of the quarter. In January 2026, AV's BADGER phased-array antenna system, which supported the Space Force SCAR project ("Satellite Communication Augmentation Resource"), received a stop-work order, directly triggering a $151 million goodwill impairment in the space business. That stop-work order was then upgraded in March 2026 into a formal Space Force termination for convenience. The dispute centered on fixed-price terms rather than technology. The Space Force shifted toward multi-vendor, commercial off-the-shelf procurement; AV can only rebid, while BADGER must seek another path as a commercial product.
One important characterization matters here because it determines how to rate the company:
The root cause of this impairment was the loss of a single large contract, not shrinkage in the entire space TAM. BADGER/SCAR was a specific government project. Formal termination means this project had a problem; it does not mean satellite communications or space-domain awareness markets are failing. The risk is concentration. Of AV's $3.0 billion of unfunded backlog, $1.4 billion (about 47%) came from SCAR-related work. With the contract terminated, this portion of order reserves has fallen away and must be won back through rebidding. In other words, the fate of one project influenced almost half of AV's future order reserves, and it has already moved from "uncertain" to the negative side. This is a single-point-of-failure-level risk that requires close monitoring.
Vertical Slice Takeaway
In one sentence, AV's internal state today is this: the engine (Autonomous Systems) is roaring at full throttle, growing 25% with the strongest policy tailwind; but the newly attached auxiliary fuel tank (space business) is leaking fuel (down 19% year over year, carrying a $151 million impairment, and tying 47% of unfunded backlog to a single project). The market is not worried about the engine. It is worried about whether this auxiliary fuel tank will keep dragging on the aircraft, or even trigger more impairments. That is exactly what "integration stumble" means in concrete terms.
Financial Review: The Other Side of High Growth Is Gross-Margin Collapse and a GAAP Loss
Opening up AV's financials reveals a highly conflicted picture: revenue is exploding, but earnings quality is deteriorating sharply. Both are true, and both come directly from the BlueHalo acquisition.
Revenue: A Five-Year Run from $395 Million to Nearly $2 Billion
First, AV's revenue track as a standalone company before the acquisition (fiscal year ended April 30):
FY2021: $394.9 million
FY2022: $445.7 million
FY2023: $540.5 million
FY2024: $716.7 million
FY2025: $820.6 million (up +14% year over year, net income of $43.6 million; AV's last full fiscal year before consolidating BlueHalo)
Revenue a little more than doubled over five years, with a compound growth rate of about 20%, a fairly solid organic growth curve. Then BlueHalo was consolidated in FY2026, and the revenue level jumped: full-year FY2026 guidance was set at $1.85-1.95 billion, more than doubling from FY2025's $820 million base. Note that this $1.85-1.95 billion is the reduced guidance (discussed below).
Q3 FY2026: A Report of "More Revenue, No More Profit, and a Swing to Loss"
Q3 FY2026 (quarter ended January 31, 2026) concentrated all the tensions in one earnings report:
| Metric | Q3 FY2026 | Meaning |
|---|---|---|
| Revenue | $408 million (+143% year over year, including about $176.5 million from BlueHalo) | Surged, but below market expectations of about $484 million |
| Gross margin | About 24% | Collapsed by 14 percentage points from about 38% in the prior-year period |
| GAAP net income | Loss of $156.6 million (-$3.15 per share) | Includes $151 million impairment + $150 million+ amortization |
| Non-GAAP EPS | $0.64 | Still profitable after excluding acquisition-related items |
| Adjusted EBITDA | About $44.5 million | Still generating cash at the operating level |
The most important item in this table is the gross-margin collapse from 38% to 24%. It has two components: first, large intangible-asset amortization from the BlueHalo acquisition (recorded in cost of goods sold); second, product-mix dilution (the space business has a lower gross-margin structure than loitering munitions). The former is accounting-driven and should improve as amortization is spread over time. The latter is structural and depends on how the business mix evolves. The market's biggest worry is whether this 24% is a "one-time trough" or the "new normal." That is why this report lists "confirmed gross-margin recovery" as one of the prerequisites for taking action.
Guidance Cut: Management Pressed the Expectations Reset Button
What hurts market confidence most after an earnings report is often not a single-quarter miss, but management's own decision to lower full-year guidance. That is the company effectively admitting "the coming period will be harder." AV reduced FY2026 full-year guidance to:
Revenue: $1.85-1.95 billion (lowered)
Non-GAAP EPS: $2.75-3.10
GAAP net loss: $201-218 million (corresponding to GAAP loss per share of about -$4.44 to -$4.10)
In other words, under GAAP, AV is expected to lose money in FY2026, a "big year" in which revenue doubles. The loss is mainly from non-cash items such as impairments and acquisition amortization. Operating-level profitability (Non-GAAP / adjusted EBITDA) remains positive. But for a growth stock trading above 5x sales, "revenue doubles, but GAAP turns to loss + guidance is cut" is the standard trigger for valuation compression.
Balance Sheet: Sixty Percent of Assets Are Goodwill and Intangibles, Leaving High Impairment Exposure
The cost of the acquisition is written directly on the balance sheet (as of January 31, 2026):
Goodwill of $2.4617 billion + intangible assets of $925.9 million = about $3.388 billion, or about 62% of total assets of $5.4536 billion.
Cash of $289.9 million; long-term debt of $727.9 million (including $747.5 million of 0% coupon convertible notes due 2030; the zero coupon is positive, but maturity/conversion dilution is a longer-term uncertainty).
Shareholders' equity of $4.2722 billion.
The core risk in this table is clear: sixty percent of assets are "purchased expectations" (goodwill + intangibles), and this quarter already proved that those expectations can be impaired (the $151 million BADGER/SCAR impairment). If cash flows from the space business or other acquired assets fall short of the assumptions made at acquisition, further impairment could be triggered. This is a sword hanging over the GAAP income statement. On the positive side, the zero-coupon convertible debt keeps interest burden very low, while $290 million of cash plus positive adjusted EBITDA means near-term repayment and liquidity risk are manageable.
Order Book: The Bull Case's Hardest Evidence
If the income statement is the bear case's ammunition depot, the order book is the bull case's strongest counter:
Funded backlog: about $1.1 billion (up materially from $726.6 million at FY2025 year-end)
Year-to-date new bookings: about $4.6 billion
Unfunded backlog: about $3.0 billion (including about $1.4 billion tied to SCAR; that contract was formally terminated by the Space Force in March 2026, so the $1.4 billion must be won back through rebidding)
9-month rolling book-to-bill: 1.6x, meaning every $1 of revenue recognized brought in $1.6 of new orders, and order reserves are growing quickly.
The order book tells the opposite story from the income statement: demand is extremely strong, and AV is capable of winning business. The question is when these orders convert into revenue, and at what gross margin. The order book is "the future"; gross-margin collapse and impairment are "the present." The bull-bear debate in this report is fundamentally a race between an ugly present and a strong future.
Financial Review Takeaway
AV's financial profile can be condensed into one sentence: a company with extremely strong orders and revenue that has doubled, but with earnings quality currently at the ugliest point of post-acquisition digestion. Gross-margin collapse, a GAAP loss, guidance cuts, and sixty percent of assets in goodwill and intangibles are all real pains that need time to be digested. But adjusted EBITDA remains positive, cash is ample, and book-to-bill is 1.6x, so the core business has not broken. This is a classic mismatch between a "reported-bottom" and an "order-book top." That is why the stock should neither be written off (fundamentals are not broken) nor loaded up on today (the pain is not over).
Business Model and Moat: Installed Base, Combat Data, and Procurement Relationships Support the "Primary Supplier" Position
To judge whether a defense company is worth holding long term, the key is whether its moat is real, wide, and durable against disruption. AV's moat has substance, though its limits also need to be assessed objectively.
Moat One: Switchblade/Puma's Three-in-One of "Installed Base + Combat Data + Program Position"
In small drones and loitering munitions, AV's moat is essentially its first-mover status as a company already in U.S. and allied inventories, with decades of installed base and combat data:
Installed base: Cumulative Puma/Raven deliveries exceed 19,000 units, equipping more than 50 allied forces. An installed base of this scale means training systems, maintenance systems, spare-parts logistics, and operator habits are already built around AV's products. Switching cost is real.
Combat data: Large-scale combat use of Switchblade in Ukraine has given AV a nearly unique set of "real battlefield iteration data" within the Western camp. Reliability, hit rate, and resistance to jamming can only be validated and iterated in combat. Latecomers cannot quickly replicate this.
Procurement sequence position: Switchblade 600 was the first weapon named for Replicator and carries a $990 million IDIQ framework; Puma won an $874 million Army contract. Once a product enters U.S. military program sequences and receives an IDIQ framework, it has an incumbent advantage in follow-on procurement.
An important correction on "exclusive": Switchblade is the "primary/most deeply deployed supplier" of U.S. squad- and platoon-level loitering munitions, but it is not the "statutory sole supplier." Earlier market narratives included the idea that AV was the sole-source supplier for the U.S. Army's LMAMS (squad- and platoon-level loitering munition) program. That needs qualification: in recent years, the U.S. military has been introducing competition into the category (for example, Anduril's ALTIUS). AV's position is "the primary supplier with the deepest deployment, largest orders, and most complete combat data," not "a legally protected sole supplier." This distinction matters. It means the moat is a relative advantage built on first-mover status, installed base, and combat use, rather than an unchallengeable monopoly.
Moat Two: Entry Barriers from Qualifications, Certifications, and Government Procurement Relationships
Defense businesses naturally carry high entry barriers: security clearances, weapon-system certifications, government contract relationships, and secure facilities. These are the "entry tickets" any new player needs years to assemble. As a long-listed defense contractor, AV has those tickets. BlueHalo's addition extends them into more sensitive areas such as space, directed energy, and cyber.
The Moat's Limits: Software-Defined Warfare and Well-Funded New Entrants
AV's moat also has real limits. It is not only facing traditional defense peers, but a group of "software-defined + vertically integrated + extremely well-capitalized" new entrants, with Anduril as the clearest example:
Anduril completed about $5.0 billion of financing in May 2026, doubling its valuation to about $61.0 billion. This is far above the earlier market perception of about $30.0 billion and is 6x AV's current market cap.
Anduril also makes loitering munitions (Altius, Anvil, Bolt-M series). In May 2026, it received a Department of Defense contract for "more than 1,000 missiles per year," directly overlapping with AV in precision strike.
Anduril's approach is "software-defined + vertical integration + self-funded capacity." The threat is that it does not rely on the traditional model of "government funds R&D, contractor delivers." Instead, it spends its own capital to build products and then sell them, potentially improving iteration speed and cost structure relative to traditional contractors.
But competition is a structural threat; it has not yet become proven share loss. AV just won the Army LASSO selection for Switchblade 400 in May 2026, showing that in real competitive selections, AV's incumbent advantage still works. Anduril's threat is "medium- to long-term structural" (capital, software, vertical integration), not "currently taking orders away from AV." It needs ongoing tracking, but it has not yet reached the level of "the moat is being breached."
Business Model Takeaway
AV's moat is real: installed base, combat data, procurement sequence position, and defense entry tickets combine around the two core categories of Switchblade/Puma to create a solid "primary supplier" status. But the moat has limits. It is a first-mover advantage, not a statutory monopoly, and it now faces structural challenges from software-defined entrants such as Anduril. Conclusion: the moat is strong enough to support AV's status as a long-term player, but not enough to justify an unchallengeable monopoly premium. This judgment flows directly into valuation: AV deserves a growth premium, but it should not be priced as a monopoly.
Industry Cycle and TAM: Riding the Strongest Policy Tailwind in This Defense Generation, "Drone Dominance"
The prior sections focused on AV itself. This section pulls the camera back to examine the size, growth, and policy direction of its market. This is the strongest and most certain part of the AV investment thesis.
Policy Tailwind: From Replicator to DAWG, Drones Have Entered the Budget Mainline
To understand AV's demand side, focus on one policy line: the U.S. Department of Defense is elevating "drones/autonomous systems" from a peripheral line item into a budget mainline.
Replicator program (launched in 2023): The Department of Defense aims to deploy thousands of all-domain autonomous systems within 18-24 months to offset adversaries' numerical advantages. AV's Switchblade 600 was the first weapon officially named for inclusion in Replicator, a landmark endorsement equivalent to the DoD personally validating AV's product.
Hegseth "drone dominance" memorandum (July 10, 2025): The Defense Secretary signed the "Unleashing U.S. Military Drone Dominance" memorandum, setting explicit goals: "one drone per squad" by the end of 2026 and deployment of more than 200,000 drones by 2027. This is a programmatic document turning drones from "specialized equipment" into "standard infantry squad equipment."
DAWG items in the FY2027 budget request: Related "Drone Dominance / DAWG" funding requests jumped from a mere $225 million to about $54.6 billion (including $39.2 billion in mandatory funding requests). This is an order-of-magnitude leap.
The necessary discount: $54.6 billion is a budget request, not appropriated funding. U.S. defense budgeting runs through a long chain from "presidential request" to "Congressional appropriation" to "actual contract," and it can be repeatedly revised by Congress and delayed by continuing resolutions (CRs). In fact, part of AV's space-business decline this quarter was caused by "government funding delays and government shutdown." So $54.6 billion is a directional and very strong tailwind signal, but it should not be treated directly as visible AV orders. It says the demand ceiling is being raised rapidly; it does not say this money becomes AV revenue tomorrow.
TAM: Multiple High-Growth Submarkets Stack Together, but Definitions Vary Widely
After acquiring BlueHalo, AV's total addressable market (TAM) spans multiple submarkets. The table below gives market-size and growth ranges around 2025. Definitions vary widely across research institutions, so ranges are used instead of single-point estimates to avoid false precision:
| Submarket | Market Size (around 2025) | CAGR | AV Exposure |
|---|---|---|---|
| Military Unmanned Aircraft Systems (UAS) | Narrow definition $16-18 billion / broad definition about $47 billion | 7%-14% | Core |
| Loitering munitions | $640 million - $4.71 billion (very large definition differences) | 11% (conservative) - 24% (optimistic) | Core |
| Counter-UAS (C-UAS) | About $6.6-8.4 billion | About 25% | BlueHalo |
| Directed-energy weapons (DEW) | About $8.0-10.0 billion | About 17% | BlueHalo |
| Electronic warfare (EW) | About $18.0-26.0 billion | About 8% | BlueHalo |
| Space situational awareness (SSA) | About $1.7-2.2 billion | 7%-11% | BlueHalo |
Two judgments matter when reading this table:
AV now sits at the intersection of multiple high-growth submarkets. Loitering munitions (potentially 20%+ growth), counter-drone (about 25%), and directed energy (about 17%) are all double-digit growth areas, and AV has exposure through its own products plus BlueHalo. This is where the BlueHalo acquisition was strategically "right": it moved AV from a single-market company into a portfolio across multiple high-growth markets.
Definition differences are huge, so beware the "maximum TAM" narrative. For example, the loitering-munition market-size range runs from $640 million to $4.71 billion, a 7x spread. That shows the category is still young and statistical definitions are not standardized. Investors should anchor on conservative definitions and treat optimistic definitions as optionality.
Industry Takeaway
AV is riding the strongest and clearest policy tailwind in this generation of defense. Drones are moving from auxiliary tools to primary battlefield consumables, and the U.S. Department of Defense has written this direction into the budget mainline through Replicator, the Hegseth memorandum, and the $54.6 billion DAWG request. AV has the purest exposure to this line (Switchblade is a Replicator-named weapon). This is the hardest part of its long-term thesis. But the caveat matters: policy requests take time and face uncertainty before becoming actual orders, and TAM definitions vary widely. The tailwind is real, but the "ceiling" should not be treated as "next year's revenue."
Horizontal Analysis: Between "Defense Primes" and "Software-Defined New Entrants," Where Does AV Stand and Is It Expensive?
Horizontal analysis answers two questions: where does AV stand in the competitive landscape, and is it expensive or cheap relative to peers? This section sets up valuation.
Competitive Landscape: AV Sits in the Middle Between "Traditional Primes" and "Software New Entrants"
Lay out defense technology by valuation multiple and business model, and AV occupies a distinctive middle position:
At one end are traditional defense primes: Lockheed Martin (LMT), General Dynamics (GD), Northrop Grumman (NOC), Raytheon (RTX), and Leidos (LDOS). They are huge, cash-flow-stable, and dividend-rich, but slow-growing and low-multiple (price-to-sales generally 1.5-2.4x). They also work on drones, but large ships turn slowly. In the "small, low-cost, attritable" new form factor, they are less flexible than specialized players.
At the other end are software-defined new entrants: Palantir (PLTR, price-to-sales above 60x, software rather than hardware), Anduril (private, valuation about $61.0 billion, implied price-to-sales about 27x), and Kratos (KTOS, price-to-sales about 7.5x). They grow fast, carry powerful narratives, and trade at high valuations, representing the future shape of "software-defined warfare."
AV stands in the middle: it grows much faster than traditional primes and trades at a much higher valuation (5.4x price-to-sales, nearly 3x LMT's 1.83x), but it is more asset-heavy, more hardware-flavored, and lower-multiple than pure-growth new entrants such as PLTR/Anduril/KTOS. It is a hybrid of "hardware franchise with real combat installed base + expanding into a multi-domain platform."
Valuation Comparables: 5.4x Price-to-Sales Is the Lower End of the "Growth Defense" Group
The table below lays out price-to-sales ratios for key comparable companies (price-to-sales = market cap / revenue; because defense earnings are heavily affected by contract cadence and amortization, price-to-sales is more suitable than P/E for horizontal comparison):
| Company | Type | Price-to-Sales (approx.) | Notes |
|---|---|---|---|
| Lockheed Martin (LMT) | Traditional prime | 1.83x | Stable low growth |
| General Dynamics (GD) | Traditional prime | 1.81x | Stable low growth |
| Northrop Grumman (NOC) | Traditional prime | 2.18x | Stable low growth |
| Raytheon (RTX) | Traditional prime | About 2.4x | Stable low growth |
| Leidos (LDOS) | Defense IT/services | About 1.5x (EV/Sales) | Low growth |
| Leonardo DRS (DRS) | Mid-sized defense | About 3.4x | Mid-growth |
| AeroVironment (AVAV) | Growth defense | About 5.4x | High growth, integration phase |
| Mercury Systems (MRCY) | Defense electronics | About 6.4x | Mid-high growth |
| Kratos (KTOS) | Growth defense | About 7.5x | High growth, drones/target drones |
| Anduril (private) | Software-defined new entrant | About 27x (implied) | Ultra-high growth |
| Palantir (PLTR) | Defense software | About 63.8x | Software, ultra-high valuation |
The key judgments from this table:
AV's 5.4x price-to-sales sits at the lower end of the "growth defense" group, cheaper than KTOS (7.5x) and MRCY (6.4x), and far below Anduril (27x) and PLTR (64x). From this angle, AV is not the most expensive growth defense name.
But it is still 2-3x traditional primes. LMT/GD/NOC are all around 1.8-2.2x. In other words, the market is still granting AV a meaningful growth premium. The premise for that premium is that "AV can deliver high growth + successful integration."
The key change: AV has already fallen from the peak's "PLTR/KTOS camp" into the lower-middle part of growth defense. At the October 2025 share price of $417, its price-to-sales ratio was about 10-12x, priced alongside KTOS and leaning toward Anduril. Today, at $204 and 5.4x, it has fallen from "ultra-high-growth pricing" to "lower-middle growth-defense pricing." This de-rating is the most important valuation change for AV today. It has released part of the risk of being priced for perfection.
Horizontal Takeaway
In the competitive landscape, AV is a growth defense name "caught between traditional primes and software new entrants." Its moat (installed base and combat data) prevents easy disruption by software new entrants, while its growth (revenue doubling and 1.6x book-to-bill) justifies a valuation above traditional primes. The current 5.4x price-to-sales ratio sits at the lower end of the growth-defense group, not the most expensive, but still carrying a 2-3x growth premium versus traditional defense. Whether that valuation is reasonable depends on whether AV can deliver high growth and move through integration pain, which is exactly what the next valuation and scenario section addresses.
Current Fundamentals: A Line-by-Line Bull-Bear Reconciliation
Compressing the prior sections into one bull-bear reconciliation table gives the final fact check before rating.
Bull Case
The strongest policy tailwind in history: Replicator named Switchblade 600; Hegseth's "one drone per squad" memorandum; FY2027 DAWG budget request jumped from $225 million to $54.6 billion. The demand ceiling is being lifted by an order of magnitude.
Exceptionally strong order book: $1.1 billion funded backlog, $4.6 billion year-to-date new bookings, $3.0 billion unfunded backlog, and 1.6x 9-month book-to-bill. Demand conversion has support at the order level.
Stable core franchise: Switchblade/Puma's installed base, combat data, and procurement-sequence position across the U.S. military and 50+ allies are real and deep. Winning the LASSO selection in May 2026 proves the incumbent advantage still works.
Valuation has substantially de-rated: The stock is down 51% from its $417 peak, and price-to-sales has fallen from 10-12x to 5.4x, releasing a meaningful portion of the risk of being priced for perfection.
Analysts remain bullish: Consensus among 19-20 analysts is "Buy," with an average target of $309.88 (about +52% from the current price). Even after the Q3 miss, multiple firms merely cut targets without cutting ratings (Baird maintained Outperform with a $235 target; KeyBanc maintained Overweight with a $295 target).
Strategic positioning is right: The BlueHalo acquisition moved AV from a single-category company into a multi-domain platform spanning loitering munitions, counter-drone, and directed energy, all high-growth areas.
Bear Case
Q3 revenue miss + guidance cut: Revenue of $408 million missed the expected $484 million, and full-year guidance was cut to $1.85-1.95 billion. Management's own expectations reset is a standard trigger for valuation compression.
Gross-margin collapse: Gross margin compressed from 38% to 24%, earnings quality deteriorated sharply, and whether "24% is the trough or the new normal" remains unclear.
$151 million impairment + GAAP loss: The BADGER/SCAR stop-work order triggered a space goodwill impairment (the contract was formally terminated by the Space Force in March 2026), and full-year GAAP net loss guidance is $201-218 million. Integration execution risk has become a real cash-and-accounting impairment.
High goodwill/intangible exposure: $2.46 billion of goodwill + $930 million of intangibles equal 62% of total assets. If acquired-asset cash flows underperform, further impairments may follow.
Order concentration risk: Of $3.0 billion in unfunded backlog, $1.4 billion (47%) was tied to the single SCAR project, which was formally terminated by the Space Force in March 2026 and must be won back through rebidding.
Valuation still carries a premium: 5.4x price-to-sales is still 2-3x traditional primes, and the company is currently GAAP loss-making. This is not a price "so cheap that risks can be ignored."
Structural competitive threat: Software-defined entrants such as Anduril (valued at $61.0 billion, about 6x AV) directly overlap in precision strike, with capital and iteration speed that could create medium- to long-term pressure.
Securities class-action lawsuit: A securities class action has already followed the earnings report, increasing legal and reputational uncertainty.
Bull-Bear Reconciliation Takeaway
The bull case is about "the future": end market, orders, franchise, and de-rating. The bear case is about "the present": miss, impairment, gross-margin collapse, guidance cut, and litigation. Both sides are factual, and they barely overlap. That means AV is not a debate over whether the fundamentals are broken (they are not), but a timing race between an ugly present and a strong future. For such a name, the right posture is not to "bet the direction," but to "wait until the ugly present has passed through one verification cycle (gross-margin recovery + integration stabilization + order conversion) before acting." That is the logic core of the Watch rating.
Valuation and Scenarios: Current Price Is at the Lower End of Fair Value, but Margin of Safety Is Not Yet Enough
Valuation Anchors
Current share price: about $204.40 (intraday on June 5, 2026, +6.75% that day)
Market cap: about $10.3 billion ($10.3B)
Shares outstanding: about 50.6 million
52-week range: $156.00 - $417.86 (current price down about 51% from the peak)
Price-to-sales (market cap / midpoint of FY26 revenue guidance of about $1.9 billion): about 5.4x
Forward P/E: not applicable under GAAP due to loss; Non-GAAP (using full-year EPS midpoint of about $2.9 from $2.75-3.10) about 70x
Three Scenarios and Intrinsic Value Ranges
Given AV's complex profile of "first-rate end market + first-rate franchise + integration pain + still carrying a premium," three scenarios are appropriate:
Bear scenario: intrinsic value $140 - $175. Trigger conditions: integration continues to stumble, further impairments occur, the DAWG budget is delayed by CRs, gross margin remains near 24% for a long period, and Anduril begins to take real orders. In this case, the market would re-rate AV from "growth defense" toward "mid-sized defense with execution issues," compressing price-to-sales to 3.5-4x and sending the stock back toward the 52-week low near $156.
Base scenario: intrinsic value $200 - $280. Trigger conditions: integration gradually stabilizes, gross margin slowly recovers from 24%, book-to-bill remains above 1.5x, and the DAWG budget lands directionally even if discounted. In that case, AV, as a "high-quality franchise riding the strongest defense tailwind," deserves about 5-6x FY2027 price-to-sales, corresponding to $200-280. The current price of $204.40 is right at the lower end of this fair-value range. Most low-to-mid analyst targets (Baird $235, KeyBanc $295, median $305) also sit in this range.
Bull scenario: intrinsic value $330 - $450. Trigger conditions: the DAWG budget is implemented substantially, Switchblade/Puma volumes scale, gross margin returns to 30%+, BlueHalo synergies materialize, and the market again values AV at the upper end of growth defense (price-to-sales returns to 7-8x). In this case, AV can challenge or exceed the prior high of $417, corresponding to the highest analyst target near $450.
Valuation Judgment: Lower End of Fair Value, but Not a Buy Point with Enough Margin of Safety
Putting the three scenarios together, the current $204 price reads as follows:
It is no longer absurdly expensive. After a 51% drawdown from the peak, it sits at the lower end of the base range. This is a "fair-to-slightly-low" position after de-rating, not the dangerous "priced for perfection" level of October 2025.
But it is not cheap enough to provide a sufficient margin of safety. The 5.4x price-to-sales ratio remains 2-3x traditional primes, while GAAP is loss-making, gross margin is at the bottom, and guidance has just been cut. If integration pain lasts longer than expected, downside to the bear range ($140-175) is real.
The ideal buy range is below $175: That is close to the 52-week low of $156 and would put price-to-sales back near just above 4x, giving investors enough discount compensation for "integration uncertainty." Buying below $175 would mean partially pre-discounting the risk of integration failure, the kind of margin-of-safety requirement appropriate for a "good company, bad timing" name.
Why "Watch" rather than "Cautious Buy"? The difference is whether the integration pain has passed through one verification cycle. AV's miss, impairment, guidance cut, and gross-margin collapse all happened in the most recent quarter. These are fresh bad-news items not yet proven to be one-off. Before seeing at least one quarter of "gross margin stabilizes and recovers + no new impairment + order conversion," buying at $204 is a bet that integration goes smoothly rather than a response to confirmed signals. Putting it on the watchlist and waiting for confirmation or a price below $175 is the more disciplined choice.
Why not "Avoid"? Because the fundamentals are not broken: the franchise is stable, orders are strong, the end market has the strongest tailwind, valuation has substantially de-rated, and analysts still see +50% upside. This is not a value trap. It is a high-quality name whose timing is not yet right. An Avoid rating would risk missing a company with a genuinely long runway.
Risk Factors
Integration execution risk (highest priority). The integration pain from the BlueHalo acquisition is already visible: $151 million impairment, gross-margin collapse, and guidance cut. Future risks include weaker-than-expected synergies, further goodwill impairments, and management integration challenges. BlueHalo's former CEO Moneymaker only serves as a strategic adviser rather than a core operating executive, so the execution burden mainly falls on legacy AV management (CEO Wahid Nawabi). This is a point to watch.
Single-project concentration risk. Of $3.0 billion in unfunded backlog, $1.4 billion (47%) was tied to the SCAR project, which the Space Force formally terminated for convenience in March 2026 and moved toward multi-vendor procurement. That $1.4 billion order reserve has fallen away and must be won back through rebidding. Failure to win the rebid would materially hit unfunded backlog and the space business, and could trigger more impairments.
Budget implementation uncertainty. The $54.6 billion DAWG figure is a "budget request," not "appropriated funding." The U.S. defense budget chain from request to contract is long and vulnerable to Congressional appropriation battles and continuing-resolution (CR) delays. This quarter's space-business decline was already partly caused by "government funding delays and government shutdown." This risk is real and already occurring.
Sustained gross-margin pressure risk. If the 24% gross margin becomes durable rather than a one-time trough, it would significantly pressure profitability and valuation. Acquisition amortization should improve over time, but product-mix dilution (the lower-margin structure of the space business) is structural.
Intensifying competition risk. Software-defined entrants such as Anduril (valued at $61.0 billion, about 6x AV) directly overlap in precision strike and may create medium- to long-term share pressure through ample capital and vertical integration. Although AV just won LASSO, this remains a structural threat that needs ongoing tracking.
Valuation risk. The 5.4x price-to-sales ratio still includes a premium, while GAAP is loss-making. If growth falls short or integration worsens, the market may further compress valuation multiples toward traditional defense levels, leaving room for a decline into the $140-175 bear range.
Legal risk. A securities class-action lawsuit has already followed the earnings report, increasing legal costs and reputational uncertainty.
Capital-structure risk. The $747.5 million zero-coupon convertible notes due 2030 create repayment or equity-dilution risk at maturity. Current cash of $290 million should be monitored relative to repayment pressure, although the zero coupon and positive EBITDA reduce near-term pressure.
Catalysts
Positive catalysts:
Substantive DAWG budget implementation: The actual amount appropriated for drone-related items in the FY2027 National Defense Authorization Act (NDAA) and appropriations bills. This is the largest potential positive catalyst.
Gross margin stabilizes and recovers: Gross margin recovering from 24% over the next 1-2 quarters would be the key confirmation that integration pain is one-off.
Orders convert into revenue: The recognition cadence of $1.1 billion funded backlog + $4.6 billion new bookings will validate the quality of the order book.
Major new Switchblade/Puma orders: New IDIQ additions, large allied orders, and follow-on Replicator procurement.
Winning the SCAR rebid: The contract has been formally terminated. If AV can regain the business in a rebid, it would resolve the uncertainty around single-project concentration risk.
BlueHalo synergies materialize: Space/directed-energy businesses return to growth and prove the strategic value of the acquisition.
Negative catalysts:
Further goodwill impairments, especially in the space business.
Another miss next quarter or another guidance cut.
Failure to win the SCAR rebid.
Competitors such as Anduril take existing AV projects in precision strike.
The DAWG budget is sharply reduced by Congress or delayed for a long period by CRs.
Unfavorable developments in the securities litigation.
Zen Horizon Convergence Summary and Pre-Mortem
How the Vertical and Horizontal Lines Meet
Vertically, AV is a high-quality franchise with 55 years of "extreme aircraft engineering" DNA. It made the right directional bet at the loitering-munition inflection point and built a deep installed base and combat-data position with Switchblade/Puma across the U.S. military and allied forces. In 2025, it used the all-stock acquisition of BlueHalo to make the key leap "from single category to multi-domain platform." The strategic direction was right, but the digestion cost is surfacing now.
Horizontally, AV stands in the middle between "traditional defense primes" and "software-defined new entrants." Its 5.4x price-to-sales ratio is at the lower end of the growth-defense group. It is not the most expensive, but it still carries a 2-3x growth premium versus traditional primes. Its moat is enough to support long-term-player status, but not enough to deserve an unchallengeable monopoly premium.
The two lines meet in valuation: the vertical "integration pain" has depressed current earnings quality (gross-margin collapse, GAAP loss), while horizontal "de-rating" has cut the valuation from 10-12x sales to 5.4x. The result is that the current $204 price sits at the lower end of the base intrinsic-value range ($200-280), a "fair-to-slightly-low, but not yet enough margin of safety" level. The strongest policy tailwind ($54.6 billion DAWG) is on the bull side; the ugliest reported-number moment (miss + impairment + guidance cut) is on the bear side. Rating Watch, ideal buy price <= $175, and wait until integration passes a verification cycle or the price offers a fuller discount.
Pre-Mortem: If This Investment Loses 50% Three Years from Now, What Is the Most Likely Cause?
Run a pre-mortem. If an investor buys at $204 and loses 50% three years later (stock falls to about $100), the most likely scripts are:
Full integration-failure script (medium probability, highest damage): BlueHalo synergies never materialize, the space business keeps shrinking, every quarter brings new goodwill impairments, and the $2.46 billion of goodwill is gradually written down. The market fully re-rates AV from "growth defense" to "mid-sized defense dragged down by a failed acquisition," compressing price-to-sales to 2-3x (toward traditional primes), while revenue is also hit by the SCAR contract termination. The stock halves into the $100 range. This is the script to watch most closely and the core reason for "Watch" rather than "Buy."
Budget-tailwind falsification script (medium-low probability, high damage): The $54.6 billion DAWG budget request is cut sharply or frozen for a long time by continuing resolutions. "One drone per squad" becomes a slogan, and drone procurement cadence falls far short of expectations. AV's high-growth narrative breaks, and the valuation premium (the 2-3x above traditional primes) is fully squeezed out.
Competitive-disruption script (medium-low probability, medium damage): With $61.0 billion of capital value and a software-defined approach, Anduril keeps taking orders in loitering munitions and drones, eroding AV's "primary supplier" position. Wins like LASSO become exceptions rather than the norm, and AV's moat proves narrower than expected.
Valuation mean-reversion script (medium probability, medium damage): Even if fundamentals improve slowly, the market continues to discount defense stocks that combine "integration phase + GAAP loss + high price-to-sales." The 5.4x multiple cannot hold and moves back below 4x. Even with revenue growth, the stock falls because of multiple compression.
What is the bullish script? Integration pain is proven one-off within 1-2 quarters (gross margin recovers and no new impairments), the DAWG budget lands substantially even after discounts, Switchblade/Puma scale under "one drone per squad" demand, AV is again priced at the upper end of growth defense, and price-to-sales returns to 7-8x. Three years later, the bull range of $330-450 becomes visible. The swing factor in that script is whether integration can deliver stabilization evidence over the next 1-2 quarters.
The pre-mortem supports the rating: the largest loss risks come from "integration failure" and "budget falsification," and both require time and subsequent quarterly reports to disprove. Before confirmation of "gross-margin stabilization + no new impairment + order conversion," buying at $204 is a bet that integration works. Waiting for evidence, or for the price to fall below $175 and compensate for uncertainty, is the way to put the odds more firmly on the investor's side. That is the full logic of the Watch rating.
Key Data Snapshot
| Item | Data | Notes |
|---|---|---|
| Ticker | AVAV (Nasdaq) | |
| Current share price | About $204.40 | Intraday on 2026-06-05, +6.75% that day |
| Market cap | About $10.3 billion ($10.3B) | |
| Shares outstanding | About 50.6 million | |
| 52-week range | $156.00 - $417.86 | Down about 51% from peak |
| Price-to-sales | About 5.4x | Market cap / FY26 revenue midpoint |
| Rating | Watch | Zen Horizon Framework |
| Ideal buy price | <= $175 | Near 52-week low, price-to-sales about 4x |
| Founded/listed | Founded in 1971 / IPO in 2007 | Founder Paul MacCready |
| CEO | Wahid Nawabi (Chairman/President/CEO) | Former BlueHalo CEO Moneymaker serves only as adviser |
| Autonomous Systems segment | Q3 revenue about $278.7 million (68%, +24.8%) | Switchblade + Puma/Raven |
| Space/Cyber/Directed Energy segment | Q3 revenue about $129.3 million (32%, -19.2%) | From BlueHalo |
| BlueHalo acquisition | All-stock, about $4.1 billion, closed 2025-05-01 | AV 60.5% / BlueHalo 39.5% |
| Q3 FY2026 revenue | $408 million (+143%) | Below expected $484 million |
| Q3 gross margin | About 24% | About 38% in prior-year period |
| Q3 GAAP net income | Loss of $156.6 million (-$3.15/share) | Includes $151 million impairment |
| Q3 Non-GAAP EPS | $0.64 | |
| Space goodwill impairment | $151 million | Triggered by BADGER/SCAR stop-work order; contract formally terminated in 2026-03 |
| FY2026 revenue guidance | $1.85-1.95 billion (lowered) | |
| FY2026 Non-GAAP EPS guidance | $2.75-3.10 | |
| FY2026 GAAP net loss guidance | $201-218 million | |
| FY2025 revenue/net income | $820.6 million / $43.6 million (+14%) | Last full year before BlueHalo consolidation |
| Goodwill + intangible assets | $2.4617 billion + $925.9 million = $3.388 billion | About 62% of total assets |
| Cash | $289.9 million | |
| Long-term debt | $727.9 million | Includes $747.5 million 0% convertible notes due 2030 |
| Shareholders' equity | $4.2722 billion | |
| Funded backlog | About $1.1 billion | $726.6 million at FY25 year-end |
| Year-to-date new bookings | About $4.6 billion | |
| Unfunded backlog | About $3.0 billion | About $1.4 billion tied to SCAR (contract terminated in 2026-03) |
| 9-month book-to-bill | 1.6x | |
| Analyst consensus | Buy (19-20 analysts) | Average target $309.88 (+52%) |
| Valuation range (bear/base/bull) | $140-175 / $200-280 / $330-450 |
Research Uncertainty Statement
This report is based on public information available as of June 5, 2026. The following uncertainties remain, and readers should make independent judgments and decisions:
Gross-margin trajectory is the core unknown: This report cannot determine whether the 24% gross margin is a one-time trough or the new normal. That directly determines AV's profitability and valuation. It is the most important variable for subsequent quarterly reports to verify.
The $54.6 billion DAWG figure is a budget request, not appropriated funding: The chain from presidential budget request to Congressional appropriation to AV contracts is long and variable. This report treats it as a "directional tailwind signal" rather than a "visible order," but the actual amount and cadence remain highly uncertain.
TAM definitions vary widely: Market-size definitions differ sharply across submarkets, especially loitering munitions at $640 million-$4.7 billion. This report uses ranges rather than single-point estimates, but actual outcomes may still differ.
Integration progress is hard to forecast in advance: Whether BlueHalo integration will produce further impairments and whether synergies can materialize depend heavily on management execution and later disclosures. This report cannot judge those outcomes ahead of time.
The final impact of SCAR/BADGER termination remains unknown: The contract was formally terminated by the Space Force in March 2026 and shifted toward multi-vendor procurement. Whether AV can win the business back through rebidding will materially affect $1.4 billion of the $3.0 billion unfunded backlog. The result is currently unknown.
Competitive evolution is uncertain: There is currently limited hard evidence of actual share transfer from new entrants such as Anduril. This report treats them as a "medium- to long-term structural threat," but the speed and severity of that evolution are difficult to predict precisely.
The share price is an intraday snapshot: $204.40 was the intraday price on 2026-06-05 (up 6.75% that day). Valuation ranges use this as the anchor; actual trading should use the latest price.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free